Atlas Trials

Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma

Clinical trial NCT02624258 · TERMINATED

Trial details

NCT number
NCT02624258
Sponsor
University of Pennsylvania
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Hodgkin Lymphoma
Start date
2015-11-01
Primary completion
2019-06-05
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.